| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 32.4 | 30.6 | 46.5 |
| Other income | -1.3 | 0.6 | 3.4 |
| Total income | 31.1 | 31.2 | 49.9 |
| Profit before exceptional items & tax | 2.5 | 6.8 | 3.7 |
| Profit before tax | 2.5 | 6.8 | 3.7 |
| Net profit | 2.9 | 4.0 | 1.9 |
| Operating margin | 8.0% | 21.8% | 7.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +52.60% |
|---|---|
| Net profit, quarter on quarter | -27.50% |
| Revenue, year on year | -30.30% |
Source
Read the filing ↗
NSE results filing, NSE: QUESTLAB. Figures extracted from the filing.
Quest Laboratories Ltd: key numbers
- Share price
- ₹87.05
- Market cap
- ₹142.7 Cr
- Revenue (annual)
- ₹111.8 Cr
- Net profit (annual)
- ₹15.02 Cr
- P/E (TTM)
- 9.5×Sector 50.4×
- Promoter holding
- 66.78%+0.00% QoQ
- FII holding
- 0.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Quest Laboratories Ltd
All →
16:52 IST
NSE
Annual General Meeting
Quest Laboratories Annual General Meeting
Quest Laboratories Limited has scheduled its 28th Annual General Meeting for September 30, 2026, to transact agenda items including financial statements and director appointments.